Literature DB >> 19924558

Arterial stiffness in dialysis patients: where are we now?

Mehmet Kanbay1, Baris Afsar, Paul Gusbeth-Tatomir, Adrian Covic.   

Abstract

Patients with end-stage renal disease treated by chronic dialysis have an impressive mortality, which more than half of this mortality is attributable to cardiovascular disease. Despite stratification for sex, race, and the presence of diabetes, cardiovascular disease mortality is 10-30 times higher in dialysis patients compared to general population. In dialysis patients, both atherosclerosis (mainly affecting the intima of the arteries) and arteriosclerosis (affecting predominantly the media of large- and middle-sized arteries diffusely) are highly prominent. Arteriosclerosis characterized by reduced arterial compliance (i.e., reduced elasticity of the arteries) is due to increased fibrosis, loss of elastic fibers, and extensive vessel wall calcification. Arteriosclerosis is closely related to arterial stiffness. A generally accepted mechanistic view is that an increase in arterial stiffness causes a premature return of reflected waves in late systole, increasing central pulse pressure, thus systolic. An increased arterial stiffness can increase the risk of stroke through several mechanisms, including an increase in central pulse pressure, influencing arterial remodeling both at the site of the extracranial and intracranial arteries, increasing carotid wall thickness, and the development of stenosis and plaques, and the likelihood of plaque rupture. Very importantly, it was also suggested that arterial stiffness itself independently plays a role in exacerbating chronic kidney disease progression. This review deals briefly with the definition of arterial stiffness, methods of measuring arterial stiffness and pathophysiology of arterial stiffness, and factors related with arterial stiffness.

Entities:  

Mesh:

Year:  2009        PMID: 19924558     DOI: 10.1007/s11255-009-9675-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  73 in total

1.  Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment.

Authors:  P Boutouyrie; C Bussy; D Hayoz; J Hengstler; N Dartois; B Laloux; H Brunner; S Laurent
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

Review 2.  Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures.

Authors:  Luc M Van Bortel; Daniel Duprez; Mirian J Starmans-Kool; Michel E Safar; Christina Giannattasio; John Cockcroft; Daniel R Kaiser; Christian Thuillez
Journal:  Am J Hypertens       Date:  2002-05       Impact factor: 2.689

Review 3.  Noninvasive assessment of cardiovascular risk: from Framingham to the future.

Authors:  R A Vogel; R M Benitez
Journal:  Rev Cardiovasc Med       Date:  2000       Impact factor: 2.930

4.  Monocyte/macrophage regulation of vascular calcification in vitro.

Authors:  Yin Tintut; Jignesh Patel; Mary Territo; Trishal Saini; Farhad Parhami; Linda L Demer
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

5.  Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.

Authors:  J T Kielstein; R H Böger; S M Bode-Böger; J Schäffer; M Barbey; K M Koch; J C Frölich
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

6.  Relation of stiffness parameter beta to carotid arteriosclerosis and silent cerebral infarction in patients on chronic hemodialysis.

Authors:  Tetsuya Ogawa; Makoto Shimada; Hideki Ishida; Nami Matsuda; Ayuko Fujiu; Yoshitaka Ando; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2009-01-29       Impact factor: 2.370

7.  Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.

Authors:  Mhairi K Sigrist; Maarten W Taal; Peter Bungay; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-10       Impact factor: 8.237

8.  Improvement in central arterial pressure waveform during hemodialysis is related to a reduction in asymmetric dimethylarginine (ADMA) levels.

Authors:  Inga Soveri; Lars Lind; Björn Wikstrom; Mihkel Zilmer; Kersti Zilmer; Bengt Fellström
Journal:  Nephron Clin Pract       Date:  2007-06-26

Review 9.  Beneficial effects of magnesium in chronic renal failure: a foe no longer.

Authors:  Ioannis P Tzanakis; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-12-30       Impact factor: 2.370

10.  Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease.

Authors:  Patrick B Mark; Arthur Doyle; Kevin G Blyth; Rajan K Patel; Robin A P Weir; Tracey Steedman; John E Foster; Henry J Dargie; Alan G Jardine
Journal:  J Cardiovasc Magn Reson       Date:  2008-08-18       Impact factor: 5.364

View more
  20 in total

1.  Screening for peripheral artery disease in dialysis patients: an opportunity for early disease detection and timely initiation of appropriate therapeutic measures.

Authors:  Kosmas I Paraskevas; Sotirios A Koupidis; Alexandros A Tzovaras; Achilleas Nikolaou; Dimitri P Mikhailidis
Journal:  Int Urol Nephrol       Date:  2011-01-06       Impact factor: 2.370

2.  Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function.

Authors:  Simona Hogas; Serban Ardeleanu; Liviu Segall; Dragomir Nicolae Serban; Ionela Lacramioara Serban; Mihai Hogas; Mugurel Apetrii; Mihai Onofriescu; Radu Sascau; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-03-19       Impact factor: 2.370

3.  Advanced glycation end products, aortic stiffness, and wave reflection in peritoneal dialysis as compared to hemodialysis.

Authors:  Fabrice Mac-Way; Véronique Couture; Mihai S Utescu; Sophie Ignace; Sacha A De Serres; Renée-Claude Loignon; Karine Marquis; Richard Larivière; Mohsen Agharazii
Journal:  Int Urol Nephrol       Date:  2013-11-17       Impact factor: 2.370

4.  Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor?

Authors:  Mehmet Kanbay; Mahmut Ilker Yilmaz; Baris Afsar; Mutlu Saglam; Emin Ozgur Akgul; Tuncer Cayci; Kayser Caglar; Hilmi Umut Unal; Mahmut Gok; Abdulgaffar Vural; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2012-03-23       Impact factor: 2.370

Review 5.  The role of uric acid in mineral bone disorders in chronic kidney disease.

Authors:  Baris Afsar; Alan A Sag; Cinar Oztosun; Masanari Kuwabara; Mario Cozzolino; Adrian Covic; Mehmet Kanbay
Journal:  J Nephrol       Date:  2019-04-27       Impact factor: 3.902

6.  Abdominal aorta and pelvic artery calcifications on plain radiographs may predict mortality in chronic kidney disease, hemodialysis and renal transplantation.

Authors:  Sinee Disthabanchong; Kotcharat Vipattawat; Bunyong Phakdeekitcharoen; Chagriya Kitiyakara; Vasant Sumethkul
Journal:  Int Urol Nephrol       Date:  2017-12-13       Impact factor: 2.370

Review 7.  Systolic blood pressure and mortality in patients on hemodialysis.

Authors:  Tara I Chang
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

8.  Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.

Authors:  Kevin S Heffernan; Jeffrey T Kuvin; Mark J Sarnak; Ronald D Perrone; Dana C Miskulin; Darya Rudym; Priya Chandra; Richard H Karas; Vandana Menon
Journal:  Nephrol Dial Transplant       Date:  2011-02-03       Impact factor: 5.992

9.  Association of peripheral artery disease and long-term mortality in hemodialysis patients.

Authors:  Shigeru Otsubo; Mariko Kitamura; Takako Wakaume; Aiji Yajima; Miwa Ishihara; Masayo Takasaki; Syuitsu Ueda; Hisayuki Sugimoto; Kimiko Otsubo; Naoki Kimata; Takashi Akiba; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2010-12-14       Impact factor: 2.370

10.  Hematological parameters can predict the extent of coronary artery disease in patients with end-stage renal disease.

Authors:  Zeynep Bal; Ugur Bal; Kaan Okyay; Mustafa Yilmaz; Serhat Balcioglu; Ozge Turgay; Senem Hasirci; Alp Aydinalp; Aylin Yildirir; Siren Sezer; Haldun Muderrisoglu
Journal:  Int Urol Nephrol       Date:  2015-08-06       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.